Combinatorial metabolic engineering of Escherichia coli for de novo production of 2′-fucosyllactose

Pathway Optimization of 2′-Fucosyllactose Production in Engineered Escherichia coli

(2021) Wen Li et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Synthesis as an Expanding Resource in Human Milk Science

(2021) Lianyan L. Xu et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

CRISPRi-Guided Multiplexed Fine-Tuning of Metabolic Flux for Enhanced Lacto-N-neotetraose Production in Bacillus subtilis

(2020) Xiaomin Dong et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Comprehensive study on Escherichia coli genomic expression: Does position really matter?

(2020) Anke R. Goormans et al.   METABOLIC ENGINEERING

Optimizing the sulfation-modification system for scale preparation of chondroitin sulfate A

(2020) Xuerong Jin et al.   CARBOHYDRATE POLYMERS

High-Titer De Novo Biosynthesis of the Predominant Human Milk Oligosaccharide 2′-Fucosyllactose from Sucrose in Escherichia coli

(2020) Katja Parschat et al.   ACS Synthetic Biology

Enhanced production of 2’‐fucosyllactose from fucose by elimination of rhamnose isomerase and arabinose isomerase in engineered Escherichia coli

(2019) Sang‐Min Jung et al.   BIOTECHNOLOGY AND BIOENGINEERING

Engineering the Substrate Transport and Cofactor Regeneration Systems for Enhancing 2′-Fucosyllactose Synthesis in Bacillus subtilis

(2019) Jieying Deng et al.   ACS Synthetic Biology

Broad-host-range application of the srfA promoter from Bacillus subtilis in Escherichia coli

(2019) Chengran Guan et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Escherichia coli as a host for metabolic engineering

(2018) Sammy Pontrelli et al.   METABOLIC ENGINEERING

Production of a human milk oligosaccharide 2′-fucosyllactose by metabolically engineered Saccharomyces cerevisiae

(2018) Sora Yu et al.   Microbial Cell Factories

Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula

(2018) Yvan Vandenplas et al.   Nutrients

Metabolic engineering of Escherichia coli for the production of 2′-fucosyllactose and 3-fucosyllactose through modular pathway enhancement

(2017) Di Huang et al.   METABOLIC ENGINEERING

Systems metabolic engineering of Escherichia coli for the heterologous production of high value molecules—a veteran at new shores

(2016) Judith Becker et al.   CURRENT OPINION IN BIOTECHNOLOGY

Overcoming the limited availability of human milk oligosaccharides: challenges and opportunities for research and application

(2016) Lars Bode et al.   NUTRITION REVIEWS

Multigene Editing in the Escherichia coli Genome via the CRISPR-Cas9 System

(2015) Yu Jiang et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

(2015) Xiao-Hui Zhang et al.   Molecular Therapy-Nucleic Acids

CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing

(2014) Tessa G. Montague et al.   NUCLEIC ACIDS RESEARCH

WbgL: a novel bacterial α1,2-fucosyltransferase for the synthesis of 2′-fucosyllactose

(2013) Leonie Engels et al.   GLYCOBIOLOGY

Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes

(2013) Zhuo-Teng Yu et al.   GLYCOBIOLOGY

Fusion protein linkers: Property, design and functionality

(2012) Xiaoying Chen et al.   ADVANCED DRUG DELIVERY REVIEWS

Human milk oligosaccharides: prebiotics and beyond

(2009) Lars Bode   NUTRITION REVIEWS